63676-12-0

Basic information

• Product Name: Methanone, [2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-pyrrolidinyl)ethoxy]phenyl ]-
• CAS NO: 63676-12-0
• Molecular Formula: C27H25NO3S
• Molecular Weight: 443.566
• Mol File: 63676-12-0.mol

Chemical Properties

• CAS DataBase Reference: Methanone, [2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-pyrrolidinyl)ethoxy]phenyl ]-(CAS DataBase Reference)
• NIST Chemistry Reference: Methanone, [2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-pyrrolidinyl)ethoxy]phenyl ]-(63676-12-0)
• EPA Substance Registry System: Methanone, [2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-pyrrolidinyl)ethoxy]phenyl ]-(63676-12-0)

Safety Data

• Hazardous Substances Data: 63676-12-0(Hazardous Substances Data)

Upstream product

• 108-98-5 thiophenol 
• 63675-96-7 2-(4-methoxy-phenyl)benzo[b]thiophen-3-yl 4-methoxyphenyl ketone 
• 27884-09-9 2-(4-methoxyphenyl)benzo[b]thiophene 
• 2632-13-5 2-Bromo-4'-methoxyacetophenone 

Downstream Products

• 215379-57-0 2-(4-hydroxyphenyl)-3-[4-[2-(1-pyrrolidinyl)-ethoxy]benzyl]benzo[b]thiophene 

Relevant articles and documents

Discovery of synthetic leishmania inhibitors by screening of a 2-arylbenzothiophene library

Tamoxifen has been shown to be active in vitro against Leishmania and effective in the treatment for leishmaniasis in murine models. Through the screening of a compound library of estrogen receptor modulator analogs, we identified the major characteristic

Thrombin inhibitors

This application relates to novel compounds of formula I (and their pharmaceutically acceptable salts), as defined herein, processes and intermediates for their preparation, pharmaceutical formulations comprising the novel compounds of formula I, and the use of defined compounds of formula I as thrombin inhibitors.

Antithrombotic Agents

This application relates to novel compounds of formula (I) (and their pharmaceutically acceptable salts), as defined herein, processes and intermediates for their preparation, pharmaceutical formulations comprising the novel compounds of formula (I), and the use of the compounds of formula (I) as thrombin inhibitors.

Antithrombotic diamines

This application relates to the use as thrombin inhibitors, coagulation inhibitors and thromboembolic disorder agents of diamines of formula I as defined herein. It also provides novel compounds of formula I, processes and intermediates for their preparation, and pharmaceutical formulations comprising the novel compounds of formula I.

COSMETIC COMPOSITION CONTAINING A NEUROPEPTIDE Y RECEPTOR ANTAGONIST

This invention relates to a cosmetic composition containing at least one NPY-antagonist component mixed with an excipient for cosmetic preparations.

2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents

Derivatives of 2-phenyl-3-aroylbenzothiophenes and 2-phenyl-3-aroylbenzothiophene-1-oxides are useful as antifertility agents. Certain of these compounds also are useful in suppressing the growth of mammary tumors.